HARBOR CAPITAL ADVISORS, INC. - FREELINE THERAPEUTICS HLDGS ownership

FREELINE THERAPEUTICS HLDGS's ticker is FRLN and the CUSIP is 35655L107. A total of 16 filers reported holding FREELINE THERAPEUTICS HLDGS in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
HARBOR CAPITAL ADVISORS, INC. ownership history of FREELINE THERAPEUTICS HLDGS
ValueSharesWeighting
Q1 2023$49,556
-22.9%
107,731
-16.6%
0.01%
-77.4%
Q4 2022$64,313
-30.1%
129,169
-2.1%
0.06%
-26.2%
Q3 2022$92,000
-28.7%
131,957
-10.0%
0.08%
-14.3%
Q2 2022$129,000
-20.4%
146,562
+1.3%
0.10%
+28.9%
Q1 2022$162,000
-55.0%
144,672
-20.7%
0.08%
-42.0%
Q4 2021$360,000182,5210.13%
Other shareholders
FREELINE THERAPEUTICS HLDGS shareholders Q1 2023
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 21,997,620$19,307,00027.43%
CHI Advisors LLC 4,862,319$4,230,0001.62%
TFG Asset Management GP Ltd 3,760,508$3,272,0000.22%
Eventide Asset Management 5,950,000$5,168,0000.11%
HARBOR CAPITAL ADVISORS, INC. 146,562$129,0000.10%
Values First Advisors, Inc. 56,300$49,0000.04%
MORGAN STANLEY 192,943$168,0000.00%
SG Americas Securities, LLC 51,663$45,0000.00%
ACADIAN ASSET MANAGEMENT LLC 26,963$23,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 34,786$31,0000.00%
View complete list of FREELINE THERAPEUTICS HLDGS shareholders